Attached files
file | filename |
---|---|
10-K - ANNUAL REPORT - Sonoma Pharmaceuticals, Inc. | oculus_10k-033115.htm |
EX-21.1 - SUBSIDIARIES OF REGISTRANT - Sonoma Pharmaceuticals, Inc. | oculus_10k-ex2101.htm |
EX-31.1 - CERTIFICATION - Sonoma Pharmaceuticals, Inc. | oculus_10k-ex3101.htm |
EX-31.2 - CERTIFICATION - Sonoma Pharmaceuticals, Inc. | oculus_10k-ex3102.htm |
EX-23.1 - CONSENT - Sonoma Pharmaceuticals, Inc. | oculus_10k-ex2301.htm |
EXCEL - IDEA: XBRL DOCUMENT - Sonoma Pharmaceuticals, Inc. | Financial_Report.xls |
Exhibit 32.1
CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officers of Oculus Innovative Sciences, Inc., a Delaware corporation (the “Company”), do hereby certify, to such officers’ knowledge, that:
The Annual Report on Form 10-K for the year ended March 31, 2015 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: June 16, 2015 | By: | /s/ Jim Schutz | |
Jim Schutz Chief Executive Officer (Principal Executive Officer) |
|||
Date: June 16, 2015 | By: | /s/ Robert Miller | |
Robert Miller Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |